Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Managing Change Control Records – V 2.0

Posted on By

SOP for Managing Change Control Records – V 2.0

Procedure for Managing Change Control Records

Department Quality Assurance (QA)/Quality Control (QC)/Production/Regulatory Affairs
SOP No. SOP/Ointment/164
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a systematic approach for managing change control records in pharmaceutical manufacturing. Change control ensures that all proposed changes to processes, equipment, documents, and materials are evaluated, approved, and documented before implementation to maintain compliance with Good Manufacturing Practices (GMP) and regulatory requirements.

2. Scope

This SOP applies to personnel in the Quality Assurance (QA), Quality Control (QC), Production, and Regulatory Affairs departments responsible for initiating, reviewing, approving, and maintaining change control records.

3. Responsibilities

  • Change Requestor: Initiates a change control request and provides justification.
  • QA Officer: Reviews change requests for impact assessment.
  • QC Analyst: Evaluates potential effects on product quality.
  • Regulatory Affairs Officer: Assesses regulatory implications.
  • Change Control Committee (CCC): Approves or rejects change requests.
  • QA Manager: Ensures proper documentation and implementation.
See also  Ointments: SOP for Validation of Filling Processes - V 2.0

4. Accountability

The QA Manager and Change Control Committee (CCC) are accountable for ensuring that all change control records comply with GMP, FDA, ICH, and WHO guidelines.

5. Procedure

5.1 Types of Changes Requiring Change Control

Change control is required for:

  • Process Changes: Modifications in manufacturing, testing, or cleaning processes.
  • Equipment Changes: Installation, replacement, or modification of machinery.
  • Material Changes: Changes in raw materials, suppliers, or packaging components.
  • Document Changes: Revisions to SOPs, batch records, and validation documents.
  • Facility Changes: Modifications in manufacturing or laboratory areas.
  • Regulatory Changes: Updates due to new compliance requirements.

5.2 Initiating a Change Control Request

  • A Change Control Request (CCR) must be initiated using the **Change Control Request Form (Annexure-1).**
  • The requestor must provide:
    • Reason for change.
    • Impact on product quality, process, or regulatory compliance.
    • Proposed implementation timeline.
  • The form must be submitted to **QA for preliminary review.**

5.3 Risk and Impact Assessment

  • QA must conduct a **Risk and Impact Assessment** to evaluate:
    • Potential impact on product safety and efficacy.
    • Need for revalidation or additional testing.
    • Effect on regulatory filings and approvals.
  • QC must assess potential effects on raw materials, in-process controls, and finished product specifications.
  • The assessment must be documented in the **Change Control Evaluation Report.**
See also  Ointments: SOP for Creating Prototype Ointment Samples for Clinical Studies - V 2.0

5.4 Approval Process

  • The **Change Control Committee (CCC)** must review the request and risk assessment.
  • Approval categories:
    • Approved: Change can be implemented with conditions.
    • Approved with Modifications: Implementation requires further review.
    • Rejected: Change poses unacceptable risk.
  • Final approval must be provided by the **QA Manager.**

5.5 Implementation of Change

  • Once approved, the change must be implemented as per the **Change Implementation Plan.**
  • Training sessions must be conducted if procedural changes are involved.
  • All implementation actions must be recorded in the **Change Implementation Log (Annexure-2).**

5.6 Verification and Effectiveness Check

  • QA must conduct a **post-implementation review** within **30 days** to verify effectiveness.
  • Key verification steps:
    • Review of manufacturing and laboratory records.
    • Evaluation of process performance.
    • Regulatory compliance check.
  • If issues arise, further corrective actions must be taken.

5.7 Archiving and Retention of Change Control Records

  • All change control records must be archived in the **Change Control Master File.**
  • Retention periods:
    • Major changes – **Minimum 10 years.**
    • Minor changes – **Minimum 5 years.**
  • Records must be available for audits and regulatory inspections.
See also  Ointments: SOP for Handling Deviations in Ointment Manufacturing - V 2.0

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • CCC – Change Control Committee
  • CCR – Change Control Request
  • FDA – Food and Drug Administration
  • ICH – International Council for Harmonisation

7. Documents

  • Change Control Request Form (Annexure-1)
  • Change Implementation Log (Annexure-2)

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • WHO Guidelines on Change Management
  • US FDA Guidance on Change Control

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Change Control Request Form

Change No. Description Initiator Date QA Approval
CC-001 Change in raw material supplier John Doe 02/02/2025 Approved

Annexure-2: Change Implementation Log

Change No. Implementation Date Verification Date Verified By Final Status
CC-001 10/02/2025 15/03/2025 QA Officer Effective

12. Revision History

Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: SOP for Checking Storage Conditions Before Issuance of Raw Materials – V 2.0
Next Post: Aerosol: SOP for Dissolution Testing of Aerosol-Delivered Products – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version